Private Brand OTC manufacturer Perrigo announced this week that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor).
This launch represents the first to market nicotine mini lozenge products for the store brand market. The mint flavored mini lozenges are marketed as a retailer owned Private brand, the product is comparable to GlaxoSmithKline’s Nicorette® Mini Lozenge. The product is indicated to reduce withdrawal symptoms, including nicotine craving, associated with quitting smoking. “This launch strengthens Perrigo’s leading store brand position in smoking cessation products, which also includes coated and uncoated flavored gums and regular size lozenges,” said Joseph C. Papa, Perrigo’s Chairman, President and Chief Executive Officer. Nicorette® Mini Lozenge is selling at an annual rate estimated at over $30 million at all retail outlets.